Interventions to Improve Medication Adherence in People with Schizophrenia: A Systematic Review
Noor Cahaya,Susi Ari Kristina,Anna Wahyuni Widayanti,James Green
DOI: https://doi.org/10.2147/PPA.S378951
2022-09-02
Patient Preference and Adherence
Abstract:Noor Cahaya, 1, 2 Susi Ari Kristina, 3 Anna Wahyuni Widayanti, 3 James Green 4 1 Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia; 2 Department of Pharmacy, Faculty of Mathematics and Science, Universitas Lambung Mangkurat, Banjarbaru, Indonesia; 3 Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia; 4 School of Allied Health and Physical Activity for Health, Health Research Institute (HRI), University of Limerick, Limerick, Ireland Correspondence: Susi Ari Kristina, Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta, 55281, Indonesia, Email Nonadherence to medications is very common in people with schizophrenia. Numerous methods have been implemented to improve medication adherence. The study aimed to determine what interventions have been used and to assess the effectiveness of these in improving medication adherence in people with schizophrenia. Two electronic databases (PubMed and Science Direct) and a manual search were used to locate RCT studies that examined interventions in medication adherence for schizophrenia, published between 2011 and 2022. The search was conducted using the terms (schizophrenia OR schizophrenic) AND (interventions OR adherence therapy) AND (medication adherence OR medication compliance). Sixteen studies were included, and relevant data were extracted and selected. Sixteen studies used interventions that involve family, health professionals (psychiatrists, psychologists, nurses, and pharmacists), SMS, and smart electronic reminders. Medication adherence was measured using medication refill records from hospital dispensing records or claim databases, electronic devices, plasma blood concentration, and participant self-reporting. Thirteen out of 15 studies showed significant improvements in adherence compared to routine care. The other three studies did not result in improved medication adherence. Interventions with diverse strategies delivered to individuals with schizophrenia showed the potential to reduce medication non-adherence in people with schizophrenia so that they can be utilized as an alternative to support treatment in people with schizophrenia in addition to antipsychotic medication. In future research strategies, it will be necessary to identify the main problems regarding nonadherence in people with schizophrenia individually and also identify the patient's perception of medication, illness, and behavior when taking medication in order to determine the next intervention that will be appropriate based on the patient's needs to improve adherence. Keywords: adherence, schizophrenia, strategies, medication, interventions, systematic review According to the 2017 Global Burden Disease report, 20 million people, or nearly 1% of the global population, suffer from schizophrenia. 1 Schizophrenia is a mental illness characterized by a wide range of symptoms. Positive symptoms (hallucinations, delusions, poor concentration), negative symptoms (apathy, lack of sense, poor or inadequate social functioning), and cognitive symptoms (disorganized thoughts, drowsiness, difficulty performing tasks, memory problems) symptoms are common in people with schizophrenia. 2 Current guidelines for schizophrenia care recommend antipsychotics as an essential part of long-term maintenance treatment for people with schizophrenia. 3 However, nonadherence to antipsychotic medication is more prevalent in people with schizophrenia, which may increase the risk of relapse, rehospitalization, suicide, and death. 4–6 Nonadherence to treatment has an impact on disease progression, leading to disease complications, disruption of physical and social functioning of the people with schizophrenia, and decreased quality of life. 7 Nonadherence to antipsychotic treatments remains an enormous challenge for clinicians and pharmacists in treating people with schizophrenia. 8,9 Many factors contribute to partial and full nonadherence to medicines for schizophrenia, including poor insight, 10 a negative attitude towards medication, 11 chronicity of illness, 12 complicated treatment regimens, side effects of medications, cost of medication, 13 and poor social functioning. Furthermore, non-adherence among patients with schizophrenia and schizoaffective disorders has been associated with cognitive impairment, depression, substance abuse, inadequate or fragmentation of care, lack of family support, 14 cultural influences, and lower socioeconomic status. 15 In the literature, "adherence" or "compliance" refers to the degree to which a person accepts advice from a heal -Abstract Truncated-
medicine, general & internal